Retagliptin

Overview

Retagliptin (SP2086) is a selective, competitive and orally active dipeptidyl peptidase-4 ( DPP-4 ) inhibitor. Retagliptin can be used for type 2 diabetes mellitus (T2DM) research.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Dipeptidyl Peptidase

Product Information

• Catalog No.: HY-112668A
• CAS No.: 1174122-54-3
• Molecular Formula: C19H18F6N4O3
• Molecular Weight: 464.36
• Purity: 98.51%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (5.38 mM); Clear solution
• Availability: In-stock

Source

Original product source